Why Hims & Hers Health, Inc. (Hims) surged this week

We recently published an article titled These 10 stocks boosted the market this week, and that's why. In this article, we will explore Hims & Hers Health, Inc. (NYSE:HIMS) position is in conflict with other stocks that have driven the market this week.

Stock markets were lower on the weekend as cautious investors repositioned their portfolios in high-risk negotiations between the U.S. and China on trade policies in global economies over months.

On a weekly basis, Dow Jones fell 0.16%, the S&P 500 fell 0.47%, while Nasdaq stock fell 0.27%.

Apart from the main indexes, 10 companies saw a bigger decline in the market, soaring in just one week of trading.

To put this list, we only considered stocks with a market cap of $20 billion and a trading volume of $5 million.

Based on the highest percentage of the closing price on May 9, these stocks were selected compared to the price a week ago or May 2.

Why Hims & Hers Health, Inc. (Hims) surged this week

Nurse on telemedicine platform consults with patients on video calls.

Hims & Hers Health, Inc. (NYSE:HIMS) shares rose 27.29% per week, ending Friday’s trading at $51.96, compared to $40.82 a week ago, as investors were pleased with more impressive revenue performance and expectations for more lasting partners over the rest of the year.

Hims & Hers Health, Inc. (NYSE: HIMS) said in its latest earnings release that its net income rose 346% to $49.5 million from $11.1 million registered in the same period last year, while revenue soared to $586 million from $278.2 million in the year.

The company said its outstanding performance supported the latest 2025 guidance, with full-year revenue expected to reach $2.3 billion to $2.4 billion, and second-quarter revenue of $530 million to $550 million.

In recent news, Hims & Hers Health, Inc. (NYSE: HIMS) has reached a long-term agreement with Novo Nordisk to jointly sell the latter’s large weight loss pill, Wegovy, which now allows users to access NovoCare Pharmacy directly through its platform.

In addition to Novo Nordisk, the company said it will reach more deals with other companies as soon as possible.

Overall, he Ranked 9 On our list of stocks that are driving the market this week. Although we acknowledge that his potential is an investment, our belief is that AI stocks have higher returns and do this in a shorter time frame. AI stocks have risen since the beginning of 2025, while popular AI stocks have lost about 25%. If you are looking for more promising AI stocks than him, but their earnings are trading at less than 5 times the price, please check out our report The cheapest AI stock.